Stroke Prevention In Atrial Fibrillation

✏Book Title : Stroke Prevention in Atrial Fibrillation
✏Author : Greg Flaker
✏Publisher : Elsevier Health Sciences
✏Release Date : 2018-05-24
✏Pages : 400
✏ISBN : 9780323554305
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Stroke Prevention in Atrial Fibrillation Book Summary : Get a quick, expert overview of stroke risks among patients with treated and untreated atrial fibrillation, in addition to best practices for management and treatment of patients with atrial fibrillation to minimize stroke risks. This concise, clinically-focused resource by Dr. Greg Flaker consolidates today’s available information on this timely topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee cardiologists as well as general practitioners treating and monitoring these patients. Covers a broad spectrum of management and treatment options for atrial fibrillation including anticoagulants, surgical and implanted devices. Presents information on recent drug trials to keep you up to date with the latest developments. Includes guidance on anticoagulation in special situations, such as cardioversion and ablation, in addition to atrial fibrillation treatment in patients with other medical conditions including cancer, major bleeding disorders, and renal or liver disease. Chapter on Risk Stratification assists in identifying patients with a high risk of stroke and predicting treatment outcomes. Chapter on The New Anticoagulation Clinic overviews best practices for patient education, compliance, follow-up monitoring, and quality assurance to aid in better patient outcomes.

✏Book Title : Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Current Status Special Situations and Unmet Needs
✏Author :
✏Publisher :
✏Release Date : 2015
✏Pages :
✏ISBN : OCLC:1052074074
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Current Status Special Situations and Unmet Needs Book Summary : In patients with non-valvular atrial fibrillation, oral anticoagulation with vitamin K antagonists reduces the risk of stroke by more than 60%. But vitamin K antagonists have limitations, including causing serious bleeding such as intracranial haemorrhage and the need for anticoagulation monitoring. In part related to these limitations, they are used in only about half of patients who should be treated according to guideline recommendations. In the past decade, oral agents have been developed that directly block the activity of thrombin (factor IIa), as well as drugs that directly inhibit activated factor X (Xa), which is the first protein in the final common pathway to the activation of thrombin. These novel non-vitamin K antagonist oral anticoagulants (NOACs) have been shown to be at least as good as warfarin for stroke prevention in atrial fibrillation and they have proved to have better safety profiles. Their net advantage is underscored by significantly lower all-cause mortality compared with warfarin in large clinical trials. Because of these features and their ease of use, they are recommended for stroke prevention in atrial fibrillation. They have also a fast onset and offset of action, but they currently lack specific antidotes. This paper addresses the role of anticoagulation for stroke prevention in atrial fibrillation in the era of NOACs, with a focus on special situations including management in the event of bleeding and around the time of procedures including cardioversion, catheter ablation, and device implantation. Also their use in patients with concomitant coronary artery disease, with advanced age, with chronic kidney disease, or with valvular heart disease will be discussed as well as the interaction of NOACs with other cardiac medication, and switching between anticoagulants.

✏Book Title : Left Atrial Appendage Closure
✏Author : Jacqueline Saw
✏Publisher : Springer
✏Release Date : 2015-11-09
✏Pages : 300
✏ISBN : 9783319162805
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Left Atrial Appendage Closure Book Summary : Percutaneous left atrial appendage (LAA) closure is an emerging technology for thromboembolic prevention in patients with atrial fibrillation (AF). The first human implantation of an LAA device occurred in 2001, and since then four devices have received CE mark approval. These devices are being widely used in Europe for LAA closure in patients who are poor candidates for long-term oral anticoagulation. In the US, the WATCHMAN device (Boston Scientific) is anticipated to receive FDA approval imminently for AF patients who are warfarin-eligible. This approval is projected to significantly expand the indications for LAA closures worldwide. Thus, the volume of procedures is anticipated to escalate. This book discusses the epidemiology of AF as a cause of stroke; the use of LAA closure in the reduction of thromboembolism with AF; early surgical approaches and novel surgical devices for LAA closure; and current percutaneous approaches and devices available for LAA closure. The emphasis of this book is on percutaneous technical approaches and contemporary trial results on the leading devices (PLAATO, WATCHMAN, Amplatzer Cardiac Plug, and LARIAT). It also reviews unapproved devices in development, in both clinical and pre-clinical phases.

✏Book Title : 3 SETTING UP AN AF STROKE PREVENTION SERVICE IN SECONDARY CARE THE SCREENING AND OPTIMISING STROKE PREVENTION IN ATRIAL FIBRILLATION SOS AF SERVICE
✏Author : Isuru Induruwa
✏Publisher :
✏Release Date : 2017
✏Pages :
✏ISBN : OCLC:1163855602
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏3 SETTING UP AN AF STROKE PREVENTION SERVICE IN SECONDARY CARE THE SCREENING AND OPTIMISING STROKE PREVENTION IN ATRIAL FIBRILLATION SOS AF SERVICE Book Summary : IntroductionOur work in 2015 showed the burden of AF in acute medical admissions is 15%, a stark contrast to previous literature estimates of 3-6%. Medical inpatients are older with multiple comorbidities and a high stroke-risk (median CHA2DS2VASc score=4.4). 50% of AF patients werenu2019t on anticoagulation on admission and only 38% of newly-diagnosed AF were discharged anticoagulated. MethodsSOS-AF was set up as a secondary-care stroke prevention service at Cambridge University Hospital, UK in October 2017. It provides in-hospital AF screening of all medical admissions, by 2 specialist nurses and 4 stroke clinicians using electronic notes and 12-lead ECG. Every AF patient not on anticoagulation is holistically risk-stratified. Patients/families are involved and educated, and anticoagulation is started where appropriate. We accept referrals from inpatient teams and primary care to our clinic and multidisciplinary meeting. Results In our first year we screened 14979 patients, identifying 393 new AF cases. The AF prevalence was 22.1% in medical admissions. We advised not to anticoagulate 158 patients, where the risks outweighed the benefits. Clinicians followed our advice 82% of the time and 402 patients were appropriately anticoagulated. We have increased local anticoagulation rates by 15% and prevented an estimated 16 cardioembolic strokes and 8 deaths, saving u00a394,600/year on bed-days and the NHS u00a3352,000/year.ConclusionSecondary-care must play an active role in stroke prevention in AF. By cost-effective screening in a high-risk population and providing specialist advice to primary and secondary care, SOS-AF delivers individualised patient care and significant financial savings to the health economy.

✏Book Title : Quick Pocket Guide to New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
✏Author : Luca Masotti
✏Publisher : SEEd
✏Release Date : 2012-06-05
✏Pages : 31
✏ISBN : 9788897419303
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Quick Pocket Guide to New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Book Summary : Cardioembolic strokes account for one third of ischemic strokes and atrial fibrillation (AF) representing the main source of this stroke subtype. The rate of stroke is 5%/year in patients with AF. Patients with AF have a 2-7 fold increased risk of stroke compared to patients without. Stroke prevention in atrial fibrillation (SPAF) is therefore of utmost importance and represents a major point in the modern management of AF. This booklet provides an overview of new oral anticoagulants used, listing their pharmacokinetis profile, the evidence of efficacy and their clinical use.

✏Book Title : Stroke Prevention
✏Author : Wolfgang Dorndorf
✏Publisher : S Karger Ag
✏Release Date : 1994
✏Pages : 199
✏ISBN : UCLA:L0067281444
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Stroke Prevention Book Summary : Stroke prevention has proved to be effective in hypertensive patients and those with atrial fibrillation and severe symptomatic carotid stenosis. Various interventional studies, based on knowledge about risk factors and improved methods of identifying stroke etiologies in individuals, have demonstrated that stroke can be avoided in a considerable number of patients. This volume brings together the latest developments in this field and considers future directions. The contributions, written by leading scientists, are organized into sections dealing with classification of strokes, risk factors, secondary prevention in vascular disease, surgical and interventional prevention, and cardioembolic stroke. Each article followed by a detailed summary in German. The book will be a valuable source of information for all those interested in this important subject.

✏Book Title : Stroke E Book
✏Author : J. P. Mohr
✏Publisher : Elsevier Health Sciences
✏Release Date : 2011-05-13
✏Pages : 1520
✏ISBN : 9781437737806
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Stroke E Book Book Summary : First published in 1986 under the editorial direction of Dr. Henry J.M. Barnett, Stroke: Pathophysiology, Diagnosis, and Management continues to provide the dependable, current answers you need to effectively combat the increasing incidence of this disease. Dr. J.P. Mohr, together with new associate editors Philip A. Wolf, James C. Grotta, Michael A. Moskowitz, Marc Mayberg, and Rüdiger von Kummer as well as a multitude of expert contributors from around the world, offer you updated and expanded coverage of mechanisms of action of commonly used drugs, neuronal angiogenesis and stem cells, basic mechanisms of spasm and hemorrhage, prevention of stroke, genetics/predisposing risk factors, and much more, equipping you to understand the latest scientific discoveries and make effective use of the newest approaches to diagnosis and treatment. Gain fresh perspectives and up-to-date insights from the world’s leading authorities on the pathophysiology, diagnosis, and management of stroke. Access the comprehensive, expert clinical guidance you need to recognize the clinical manifestations of stroke, use the latest laboratory and imaging studies to arrive at a diagnosis, and generate an effective medical and surgical treatment plan. Make efficient and accurate diagnoses with the aid of abundant full-color CT images and pathology slides. Stay up to date on hot topics such as mechanisms of action of commonly used drugs, neuronal angiogenesis and stem cells, basic mechanisms of spasm and hemorrhage, prevention of stroke, genetics/predisposing risk factors, and much more.

✏Book Title : Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation
✏Author :
✏Publisher :
✏Release Date : 2015
✏Pages :
✏ISBN : OCLC:1051808906
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation Book Summary : Abstract : Abstract: Guidelines recommended oral anticoagulant (OAC) for ischemic stroke patients related to atrial fibrillation (AF). But, underprescription or underdose of warfarin was observed worldwide. We aimed to explore if the use of antithrombotic therapy in nonvalvular AF (NVAF) ischemic stroke patients improved after novel oral anticoagulants (NOACs) became available. Between January 2011 to December 2013, 360 acute ischemic stroke patients related to NVAF were recruited. Patients were categorized into 2 groups based on the date (July 2012) of NOACs' availability. There were 184 patients recruited before July 2012, and whereas 176 patients after July 2012. Demographic data, interested factors, and the percentage of patient on OAC were compared. One month after discharge, percentage of OAC utilization was significantly higher (29% versus 41%; P = 0.022) as well as effective anticoagulation (22.2% versus 80.6%; P

✏Book Title : Handbook of Stroke Prevention in Clinical Practice
✏Author : Karen L. Furie
✏Publisher : Springer Science & Business Media
✏Release Date : 2004-04-28
✏Pages : 310
✏ISBN : 9781592597697
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Handbook of Stroke Prevention in Clinical Practice Book Summary : Despite major advances in the understanding of stroke mechanisms that have occurred over the past quarter century, stroke continues to rank among the leading causes of death and disability worldwide. Although currently it may be difficult to believe, early doubts were expressed as to whether inter ventions in risk factors for either coronary disease or stroke would actually lead to a reduction in the incidence of these disorders. However, large clini cal trials in hypertension, carotid disease, atrial fibrillation, and antithrombotic and antiplatelet therapies have effectively demonstrated the efficacy of these targeted interventions in reducing stroke incidence. More recently, after earlier uncertainty regarding the role of elevated lipids as a risk factor for stroke, clinical trials of the statins have also demonstrated a significant reduction in the incidence of ischemic stroke. However, as em phasized in Handbook of Stroke Prevention in Clinical Practice, despite these gains and the initial decline in stroke incidence that did occur in the 1960s and 1970s, the incidence of stroke disappointingly has failed to show a fur ther significant decline since that time. The editors of Handbook of Stroke Prevention in Clinical Practice raise the very important question of whether recognized strategies for stroke preven tion have been widely or effectively implemented. They correctly empha size the critical importance of identifying the mechanism of stroke in each patient so as to properly direct prevention and treatment. As Dr.

✏Book Title : Stroke Prevention
✏Author : John W. Norris
✏Publisher : Oxford University Press
✏Release Date : 2001-04-12
✏Pages : 368
✏ISBN : 9780199761111
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Stroke Prevention Book Summary : The treatment of stroke remains ineffective, and prevention is the key issue for this common disease. Norris and Hachinski have recruited an international group of experts to provide a comprehensive, critical review of the evidence on the primary and secondary prevention of cerebrovascular disease and to translate this information into clinical practice. The authors present fresh information on established risk factors such as atrial fibrillation, smoking and hypertension and on new risk factors such as homocysteinemia and the paradoxical role of alcohol. They cover the protective effects of lifestyle changes, diet, exercise, and estrogen. Under secondary prevention, they deal with aspirin, antiplatelet therapy, surgical measures to prevent stroke, angioplasty and stenting, and the importance of cardiac anomalies increasingly revealed by high-definition imaging. While endarterectomy remains controversial for asymptomatic carotid stenosis, it has been clearly defined as the single most effective strategy in secondary prevention. In a concluding section that will be particularly valuable to clinical readers, the authors provide a lucid, balanced discussion of how the findings from clinical trials, where patients are highly selected, closely monitored, and given the highest standard of care, can be effectively applied in the everyday practice of medicine.

✏Book Title : Stroke Prevention in Atrial Fibrillation
✏Author :
✏Publisher :
✏Release Date : 2016
✏Pages :
✏ISBN : OCLC:1052080076
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Stroke Prevention in Atrial Fibrillation Book Summary : Atrial fibrillation is found in a third of all ischaemic strokes, even more after post-stroke atrial fibrillation monitoring. Data from stroke registries show that both unknown and untreated or under treated atrial fibrillation is responsible for most of these strokes, which are often fatal or debilitating. Most could be prevented if efforts were directed towards detection of atrial fibrillation before stroke occurs, through screening or case finding, and treatment of all patients with atrial fibrillation at increased risk of stroke with well-controlled vitamin K antagonists or non-vitamin K antagonist anticoagulants. The default strategy should be to offer anticoagulant thromboprophylaxis to all patients with atrial fibrillation unless defined as truly low risk by simple validated risk scores, such as CHA2 DS2 -VASc. Assessment of bleeding risk using the HAS-BLED score should focus attention on reversible bleeding risk factors. Finally, patients need support from physicians and various other sources to start anticoagulant treatment and to ensure adherence to and persistence with treatment in the long term.

✏Book Title : Stroke Prevention in Clinical Practice
✏Author : Daryll M. Baker
✏Publisher : Springer Science & Business Media
✏Release Date : 2007-12-10
✏Pages : 131
✏ISBN : 9781852339647
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Stroke Prevention in Clinical Practice Book Summary : This book provides a short clear text to explain how to accurately diagnose a TIA, determine what investigations are indicated and how and when to intervene to reduce the risk of stroke. Short chapters are written in point form with clear diagrams and figures.

✏Book Title : Stroke in Atrial Fibrillation An Issue of Cardiac Electrophysiology Clinics
✏Author : Samuel J. Asirvatham
✏Publisher : Elsevier Health Sciences
✏Release Date : 2014-09-05
✏Pages : 649
✏ISBN : 9780323287005
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Stroke in Atrial Fibrillation An Issue of Cardiac Electrophysiology Clinics Book Summary : Because atrial fibrillation promotes the formation of blood clots that can travel to the brain and block an artery, atrial fibrillation independently increases the risk of ischemic stroke four-to-five-fold. In this issue expert authors review drug therapies for stroke prevention, use of the new anticoagulants, ablation strategies for stroke prevention, LAA closure for stroke prevention, stroke in heart rhythm device patients, transesophageal echo in atrial fibrillation, and other topics important to the management of this serious complication.

✏Book Title : SECONDARY PREVENTION FOR STROKE BY DIRECT ORAL ANTICOAGULANTS DOACS IN PATIENTS WITH ATRIAL FIBRILLATION AND CANCER
✏Author : Tuyoshi Uesugi
✏Publisher :
✏Release Date : 2017
✏Pages :
✏ISBN : OCLC:1163833512
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏SECONDARY PREVENTION FOR STROKE BY DIRECT ORAL ANTICOAGULANTS DOACS IN PATIENTS WITH ATRIAL FIBRILLATION AND CANCER Book Summary : Background and Aims:Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in cancer survivors. However, it is still unclear about the efficacy and safety of direct oral anticoagulants (DOACs) for prevention in cardioembolic (CE) stroke patients with atrial fibrillation(AF) and cancer.Methods:We extracted the patients with AF and active cancer from consecutive CE stroke 1250 patients treated with DOACs for secondary prevention in our stroke data base from March, 2011 to the April, 2018 and analyzed retrospectivelyResults:The number of the consecutive CE stroke patients which coexisted AF and active cancer was 88(7.0%), interestingly that was significant higher than in non-CE stroke patients with cancer (3%). In CE patients with cancer, the CHADS2 Score was significant lower (3.0u00b11.1) than CE stroke patients without cancer (3.9u00b10.9). In 66.7% of patients with cancer, chemotherapy was carried out, considering the interaction of DOACs and anticancer agents to avoid organ functional disorders. Whereas no significant decline of renal or liver function was observed after chemotherapy, notably, heart failure significantly occurred(34%). Overall, in an observation period (median: 606 days and IQR: 331-1333), Ischemic-stroke was observed in 2.3% of patients with AF and cancer, no intracranial-hemorrhage, no major bleeding, and minor bleeding 4.3%. Mortality was 12.7% (due to a cancer or heart failure).Conclusions:The efficacy and safety of DOACs were suggested in CE stroke patients with AF and cancer. It is important to consider the interaction with the pharmacokinetics of each DOACs with anticancer agents, incorporating the insight of cardio-oncology into the stroke prevention .

✏Book Title : Antiplatelet Therapy in ACS and A Fib
✏Author : Victor L. Serebruany
✏Publisher : Karger Medical and Scientific Publishers
✏Release Date : 2012
✏Pages : 170
✏ISBN : 9783318021684
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Antiplatelet Therapy in ACS and A Fib Book Summary : Written by top experts in the field Platelets play a critical role in the pathophysiology of acute coronary syndromes (ACS) and thromboembolic complications associated with atrial fibrillation. Anticoagulant and antiplatelet therapies are central to the treatment of ACS and atrial fibrillation. Over the last several decades, a better understanding of the pathogenesis of coronary heart disease and atrial fibrillation has led to refinements in antithrombotic strategies and clinical outcomes. With this in mind, some of the issues outlined in this book are new insights in genetic testing and modification of individualized antiplatelet therapy based on rapid bedside platelet analyzers. Most importantly, the current update of pros and cons of novel antiplatelet agents such as prasugrel and ticagrelor are provided in detail. Conventional antiplatelet strategies with aspirin and clopidogrel are also discussed. Special attention is devoted to experimental antiplatelet agents like PAR-1 thrombin receptor antagonists or aptamers. The ability to focus on different diseases beyond ACS, including heart failure and atrial fibrillation, distinguishes this publication. Each chapter was written by top experts in the field and scientists with the utmost authority and expertise to provide cardiologists, internists, and clinical pharmacologists with the latest updates.

✏Book Title : Stroke Dementia and Atrial Fibrillation
✏Author : Vincenzo Russo
✏Publisher :
✏Release Date : 2020-09-11
✏Pages : 212
✏ISBN : 3039366726
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Stroke Dementia and Atrial Fibrillation Book Summary : The present special issue will lead you to discover the association between cerebrovascular events, cognitive impairment and atrial fibrillation, through update reviews and original articles exploring the pathophysiological mechanisms underpinning this association and describing the latest results in term of stroke prevention in AF. An interesting scientific journey that reflects the recent advances in pharmacological treatments and interventional procedures involving both mind and heart.

✏Book Title : Co morbidities in Heart Failure An Issue of Heart Failure Clinics E Book
✏Author : Faiez Zannad
✏Publisher : Elsevier Health Sciences
✏Release Date : 2014-03-30
✏Pages : 160
✏ISBN : 9780323296953
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Co morbidities in Heart Failure An Issue of Heart Failure Clinics E Book Book Summary : This issue of Heart Failure Clinics examines co-morbidities in patients with heart failure. Topics include hypertension, diabetes, pulmonary disorders, cardiorenal syndrome, anemia, depression, atrial fibrillation, obesity and cardiac cachexia, peripheral vascular disease, rheumatologic disorders, co-morbidities and polypharmacy, coronary artery disease, and clinical trials.

✏Book Title : Cardiology E Book
✏Author : Michael H. Crawford
✏Publisher : Elsevier Health Sciences
✏Release Date : 2009-09-18
✏Pages : 1984
✏ISBN : 9780723436447
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Cardiology E Book Book Summary : With your heavy case load, you can't afford to waste time searching for answers. Cardiology, 3rd Edition, by Drs. Crawford, DiMarco, and Paulus, offers you just the practical, problem-based guidance you need to quickly overcome any clinical challenge. 8 color-coded sections cover the 8 major clinical syndromes of cardiovascular disease—each section a virtual "mini textbook" on its topic! 40 new chapters keep you up to date with the latest advances in the field, while more than 2,000 lavish, high-quality illustrations, color photographs, tables, and ECGs capture clinical manifestations as they present in practice. It’s current, actionable information that you can put to work immediately for your patients! Offers a problem-based approach that integrates basic science, diagnostic investigations, and therapeutic management in one place for each cardiovascular disease so you can quickly find all of the actionable knowledge you need without flipping from one section to another. Features introductory bulleted highlights in each chapter that present the most pertinent information at a glance. Presents abundant algorithms to expedite clinical decision making. Includes more than 2,000 lavish, high-quality illustrations, color photographs, tables, and ECGs that capture clinical manifestations as they present in practice, and promote readability and retention. Includes 40 new chapters including Inherited Arrhythmia Syndromes, Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy in CHD, Management of the Cyanotic Patient with CHD, Special Problems for the Cardiology Consultant Dealing with Bariatric/Gastric Bypass — and many more — that equip you with all of the latest knowledge. Presents "Special Problem" sections—many new to this edition—that provide practical advice on problems that can be difficult to treat.

✏Book Title : SAFETY AND EFFICACY OF DABIGATRAN FOR SECONDARY STROKE PREVENTION IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION MULTICENTER PROSPECTIVE REGISTRY BY TAIWAN STROKE SOCIETY
✏Author : YA-JU LIN
✏Publisher :
✏Release Date : 2017
✏Pages :
✏ISBN : OCLC:1163810887
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏SAFETY AND EFFICACY OF DABIGATRAN FOR SECONDARY STROKE PREVENTION IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION MULTICENTER PROSPECTIVE REGISTRY BY TAIWAN STROKE SOCIETY Book Summary : Background and AimsStroke in nonvalvular atrial fibrillation(NVAF) patients is usually devastating if not adequately prevented. AF patients with stroke are at higher risk of recurrence. Dabigatran, a direct thrombin inhibitor has had been approved as an appropriate preventive option. This multicenter observational prospective cohort study tried to investigate the safety and efficacy of Dabigatran prescribed under routine clinical practice for secondary stroke prevention in NVAF patients.MethodPatients with history of stroke or TIA, started Dabigatran within 3-months of study initiation or after new index-stroke were enrolled. After patientsu2019 consent, we recorded data on their demographics, AF disease information/medical history, laboratory tests and concomitant medications during baseline and follow-up visits. The rate of stroke recurrence, bleeding, gastrointestinal events as well as the drug adherence were evaluated. ResultsFrom Dec 2013 till Apr 2017, 653 patients (M/F:399/254) participated, mean age 71.4u00b110.4, mean follow-up 205 days. The median CHA2DS2VASc score was 5; HAS-BLED scale was 3. Low dose Dabigatran (110 mg BID) was prescribed in 555(85%) patients. Recurrent ischemic stroke was diagnosed in 18 patients/TIA in 2; MI in 5; death in 17 (3%; 0.77 %; 2.6%) (5.45%; 1.36%; 4.6% per year). Hemorrhagic complications were recorded in 46 patients, 56 events (8.6%; 12.5% per year), of which 13 were major bleeding (1.99%; 3.5% per year): intracerebral (3), gastrointestinal (7), genitourinary (2), retroperitoneum (1). Male, ageu226775 y/o were risks of bleeding but no difference between low dose and standard dose. 138 (21.1% ) patients withdrawn prematurely, 37% due to adverse events. ConclusionThe use of low dose Dabigatran in real-world clinical setting among high risk NVAF patients in Taiwan was still associated with comparable efficacy and acceptable safety outcomes.

✏Book Title : Difficult Decisions in Clinical Electrophysiology A Case Based Approach An Issue of Cardiac Electrophysiology Clinics E Book
✏Author : Mark C. Haigney
✏Publisher : Elsevier Health Sciences
✏Release Date : 2012-10-01
✏Pages : 184
✏ISBN : 9781455745630
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Difficult Decisions in Clinical Electrophysiology A Case Based Approach An Issue of Cardiac Electrophysiology Clinics E Book Book Summary : This issue consists of 17 case studies, each involving a difficult decision that has to be made in the catheterization laboratory. Reading about the cases and seeing the ECGs will help cardiac electrophysiologists sharpen their clinical skills. The cases are also useful reading for those studying for board certification.

✏Book Title : Current Management Guidelines in Thoracic Surgery An Issue of Thoracic Surgery Clinics E Book
✏Author : M. Blair Marshall
✏Publisher : Elsevier Health Sciences
✏Release Date : 2012-02-28
✏Pages : 152
✏ISBN : 9781455743193
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Current Management Guidelines in Thoracic Surgery An Issue of Thoracic Surgery Clinics E Book Book Summary : This issue highlights management issues surrounding specific subjects within the clinical practice of thoracic surgery. The articles represent areas of thoracic surgery where there may be controversy, lack of consensus, or evolution. Each author summarizes the available literature with the addition of his or her own personal expertise.

✏Book Title : Physical Medicine and Rehabilitation E Book
✏Author : Randall L. Braddom
✏Publisher : Elsevier Health Sciences
✏Release Date : 2010-12-07
✏Pages : 1472
✏ISBN : 9781437735635
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Physical Medicine and Rehabilitation E Book Book Summary : Physical Medicine and Rehabilitation presents today’s best physiatry knowledge and techniques, ideal for the whole rehabilitation team. This trusted reference delivers the proven science and comprehensive guidance you need to offer every patient maximum pain relief and optimal return to function. In this new edition, Dr. Randall L. Braddom covers current developments in interventional injection procedures, the management of chronic pain, integrative medicine, recent changes in the focus of stroke and brain injury rehabilitation, and much more. Access the complete contents online along with 1000 self-assessment questions at www.expertconsult.com. Gain a clear visual understanding of important concepts thanks to 1400 detailed illustrations—1000 in full color. Find and apply the information you need easily with each chapter carefully edited by Dr. Braddom and his associates for consistency, succinctness, and readability. Access the fully searchable text online at Expert Consult, as well as 1000 self-assessment questions. Master axial and peripheral joint injections through in-depth coverage of the indications for and limitations of these therapies. Make optimal use of ultrasound in diagnosis and treatment. Get a broader perspective on your field from a new chapter on PM&R in the international community.

✏Book Title : Aging Heart Disease and Its Management
✏Author : Niloo M. Edwards
✏Publisher : Springer Science & Business Media
✏Release Date : 2002-11-14
✏Pages : 390
✏ISBN : 9781592593576
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Aging Heart Disease and Its Management Book Summary : Reviews the best therapies and surgical techniques available to provide quality care for the elderly cardiac patient and of those areas that require further research. The authors detail preventive therapies and the cardiovascular syndromes that disproportionately afflict the older individual, including arrhythmias (particularly atrial fibrillation), syncope, heart failure (particularly diastolic heart failure), and ischemic heart disease. They also delineate the surgical management of the heart patient with discussions of postoperative management and its complications and of specific surgical procedures such as coronary artery bypass grafting, valve surgery, pacemaker and defibibrillators, and surgical management of heart failure.

✏Book Title : Electrophysiological Disorders of the Heart E Book
✏Author : Sanjeev Saksena
✏Publisher : Elsevier Health Sciences
✏Release Date : 2011-12-12
✏Pages : 1488
✏ISBN : 9781437709711
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Electrophysiological Disorders of the Heart E Book Book Summary : The new edition of Electrophysiological Disorders of the Heart helps you diagnose and treat a full range of heart rhythm disorders using today’s latest technologies and therapies. It provides practical, hands-on coverage of hot topics such as pediatric EP, imaging, echocardiography-guided EP procedures, regenerative therapies, cardiac pacing, and more. Now available in a new full-color format, the title also includes easy online access at www.expertconsult.com. Discover new ways to treat and manage the full range of heart rhythm disorders with content focused on common clinical features, diagnosis, and management. Review expert management strategies to help you handle complex patient problems. Stay current with the latest molecular and technical advances as well as new treatment options implemented over the last few years. Use the latest technologies and devices to accurately diagnose and manage heart rhythm disorders. Consult new and expanded coverage of regenerative therapies, echo-guided procedures, cardiac pacing, and CRT, as well as a new section on pediatric electrophysiology and imaging. Enjoy improved visual guidance with many new full-color images. Log on to www.expertconsult.com to easily search the complete contents online and access a downloadable image library.

✏Book Title : Atrial Fibrillation An Issue of Cardiology Clinics E Book
✏Author : Hakan Oral
✏Publisher : Elsevier Health Sciences
✏Release Date : 2014-11-05
✏Pages :
✏ISBN : 9780323323680
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Atrial Fibrillation An Issue of Cardiology Clinics E Book Book Summary : Atrial fibrillation is the most common cardiac arrhythmia. This issue of Cardiology Clinics examines following facets of atrial fibrillation: epidemiology and societal impact, risk factors and genetics, mechanisms, diagnosis and follow-up, rate versus rhythm control, antiarrhythmic drug therapy, catheter ablation, surgery, antithrombotic and anticoagulant therapy, left atrial appendage exclusion, management of patients with heart failure and structural heart disease, and novel treatment paradigms.

✏Book Title : Approaches to Left Atrial Appendage Exclusion An Issue of Interventional Cardiology Clinics
✏Author : Randall Lee
✏Publisher : Elsevier Health Sciences
✏Release Date : 2014-04-10
✏Pages : 156
✏ISBN : 9780323290036
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Approaches to Left Atrial Appendage Exclusion An Issue of Interventional Cardiology Clinics Book Summary : This issue of Interventional Cardiology Clinics examines approaches to left atrial appendage exclusion. Topics include stroke and bleeding risks in patients with atrial fibrillation, embryology and anatomy, rationale, catheter-based endocardial closure, pericardial access, catheter-based epicardial closure, surgical closure, device and left atrial appendage specific characteristic for successful closure, clinical results, the role of CTA and MRA imaging, imaging with TEE, post-procedural management, and prevention and management of complications.

✏Book Title : Anticoagulants An Issue of Clinics in Laboratory Medicine
✏Author : Jerrold H. Levy
✏Publisher : Elsevier Health Sciences
✏Release Date : 2014-08-28
✏Pages : 664
✏ISBN : 9780323323307
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Anticoagulants An Issue of Clinics in Laboratory Medicine Book Summary : Topics in this clinically focused publication devoted to Anticoagulants are: Antithrombin clinical applications and anti-inflammatory effects; Pharmacology and laboratory testing of oral direct thrombin inhibitor Dabigatran; Pharmacology and laboratory testing of the oral Xa inhibitors; Clincial use of the new oral anticoagulants; Pharmacology and safety of new oral anticoagulants-the challenge of bleeding; Emergency reversal of Warfarin anticoagulation - prothrombin complex concentrate compared with plasma; Prothrombin complex concentrate as reversal agent for new oral anticoagulants - lessons from prelinical models; Bleeding with new oral anticoagulants - clinical presentation and management; Treatment of ICH with new oral anticoagulants - a neurologist's view; Management of anticoagulation agents in trauma patients; and Anticoagulation and pediatric patients.

✏Book Title : Dynamic Echocardiography E Book
✏Author : Roberto Lang
✏Publisher : Elsevier Health Sciences
✏Release Date : 2010-07-19
✏Pages : 496
✏ISBN : 9781455710034
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Dynamic Echocardiography E Book Book Summary : Dynamic Echocardiography combines textbook, case-based, and multimedia approaches to cover the latest advances in this rapidly evolving specialty. The experts at the American Society of Echocardiography (ASE) present new developments in 3D echocardiography, aortic and mitral valve disease, interventional and intraoperative echocardiography, new technologies, and more. You’ll have everything you need to apply the latest techniques in echocardiography and get the best results...in print and online at www.expertconsult.com. Stay current on aortic and mitral valve disease, prosthetic heart valve disease, interventional and intraoperative echocardiography, transesophageal echocardiography, CAD, complications of MI, pericardial disease and intracardiac masses, myocardial diseases, heart failure filling pressures, CRT, CHD, and new technologies. Understand the advantages of 3D echocardiography and see how to effectively use this novel technique. Appreciate the visual nuances and details of echocardiography thanks to beautiful, full-color illustrations. Tap into the expertise of authorities from the American Society of Echocardiography.

✏Book Title : Atrial High rate Episodes and Stroke Prevention
✏Author :
✏Publisher :
✏Release Date : 2016
✏Pages :
✏ISBN : OCLC:1051964352
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Atrial High rate Episodes and Stroke Prevention Book Summary : While the benefit of oral anticoagulants (OACs) for stroke prevention in patients with atrial fibrillation (AF) is well established, it is not known whether oral anticoagulation is indicated in patients with atrial high-rate episodes (AHRE) recorded on a cardiac implantable electronic device, sometimes also called subclinical AF, and lasting for at least 6 min in the absence of clinically diagnosed AF. Clinical evidence has shown that short episodes of rapid atrial tachycarrhythmias are often detected in patients presenting with stroke and transient ischaemic attack. Patients with AHRE have a higher likelihood of suffering from subsequent strokes, but their stroke rate seems lower than in patients with diagnosed AF, and not all AHRE episodes correspond to AF. The prognostic and pathological significance of AHRE is not yet fully understood. Clinical trials of OAC therapy are being conducted to determine whether therapeutic intervention would be beneficial to patients experiencing AHRE in terms of reducing the risk of stroke.

✏Book Title : Management of Atrial Fibrillation
✏Author : Mohammad Shenasa
✏Publisher : OUP Oxford
✏Release Date : 2014-12-11
✏Pages : 175
✏ISBN : 9780191509841
✏Available Language : English, Spanish, And French

---

Click Here To Get Book

✏Management of Atrial Fibrillation Book Summary : Atrial Fibrillation is becoming a twenty-first century epidemic. It remains the most common form of sustained arrhythmia with significant mortality, morbidity and cost to the health care system. It is the most common cause of hospital admissions among all arrhythmias. Its prevalence increases with the aging population and is often associated with many other cardiac and noncardiac conditions, most notably congestive heart failure, hypertension, diabetes, and coronary artery disease. Although significant progress in understanding the epidemiology, natural history and mechanism has been made, the antiarrhythmic therapy in patients with Atrial Fibrillation is less satisfactory. Management of Atrial Fibrillation: A Practical Approach is the perfect pocket guide for those who care for patients afflicted by Atrial Fibrillation. From the history of the condition and the subsets of patients, to therapeutic and preventive procedures, Management of Atrial Fibrillation comprehensively covers all aspects in managing this increasingly prevalent disorder. Written by leading authorities in the field with vast experience in practical medicine, the book creates a clinically orientated, evidence based "fast fact" type resource for cardiologists, trainees and related healthcare professionals.